We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

23 hedge funds and large institutions have $31.3M invested in Global Cord Blood Corporation in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more call options, than puts

Call options by funds: $167K | Put options by funds: $80K

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

4% less funds holding

Funds holding: 2423 (-1)

19% less capital invested

Capital invested by funds: $38.7M → $31.3M (-$7.45M)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
23
Holders Change
-1
Holders Change %
-4.17%
% of All Funds
0.37%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
Increased
1
Reduced
2
Closed
1
Calls
$167K
Puts
$80K
Net Calls
+$87K
Net Calls Change
-$88K

Top Buyers

Rank Fund Capital Flow
1
Simplex Trading
Simplex Trading
Illinois
+$6.3K

CO Hedge Fund Activity: Q4 2022 in Review

23 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2022, worth a combined $31.3M — down 19% from $38.7M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CO and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Simplex Trading, adding an estimated $6.3K. The largest seller was Morgan Stanley, cutting an estimated $188.

  • 23 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2022, down from 24 in Q3 2022.
  • Funds reported $31.3M of Global Cord Blood Corporation stock for Q4 2022, down 19% quarter-over-quarter.
  • 0 funds opened new Global Cord Blood Corporation positions in Q4 2022 and 1 closed out, a net change of -1 holder.
  • The largest Global Cord Blood Corporation buyer in Q4 2022 was Simplex Trading, an estimated $6.3K added.
  • The largest Global Cord Blood Corporation seller in Q4 2022 was Morgan Stanley, an estimated $188 sold.

Based on aggregated 13F filings for Q4 2022.